Melhem Scientific is the research and scientific intelligence arm of the platform. It conducts applied research in artificial intelligence, global health informatics, and translational health science — building the intellectual and technical infrastructure that underpins the organization's broader strategy.
Working through formal academic relationships and institutional channels, Melhem Scientific connects research to execution — translating scientific inquiry into deployable systems that operate at national and regional scale.
Manages institutional academic relationships, research collaboration frameworks, and scholarly engagement across partner universities and research centers globally.
Develops and deploys machine learning systems and health data infrastructure for national health systems, ministries of health, and population-level programs.
Manages government-level engagement, intergovernmental coordination, and the strategic communication of the platform's research and scientific agenda.
Melhem Pharmaceuticals addresses one of the most consequential challenges in global health: ensuring that populations in underserved and high-growth markets have access to the pharmaceutical systems they require. The entity designs and executes access strategies from the clinical level to the national supply chain.
Its work spans distribution architecture, clinical integration protocols, and the regulatory and policy engagement required to operationalize pharmaceutical access in complex environments.
Designs frameworks for sustainable pharmaceutical access across national and regional healthcare systems, with particular focus on middle- and low-income markets where structural gaps persist.
Manages the clinical-level pathways through which pharmaceutical solutions are integrated into care delivery systems — ensuring alignment between supply, access, and clinical standards.
Develops and manages national and regional pharmaceutical distribution infrastructure, coordinating logistics, cold chain, and regulatory compliance across priority markets.
Provides strategic advisory at the government and institutional level on pharmaceutical policy, national formulary development, and long-term health system investment frameworks.
Melhem Investments LLC is the financial and intellectual property holding entity of the platform. It holds 100% of the intellectual property generated across the organization and manages the commercial infrastructure through which that IP is licensed, structured, and deployed into markets.
As the commercialization engine of the holding company, it creates the financial frameworks that translate research and operational output into durable, scalable assets — enabling the organization to maintain strategic ownership of its most valuable outputs while engaging the capital markets necessary for long-term expansion.
Holds and manages the full portfolio of proprietary technology, research outputs, and system architectures developed across the platform.
Designs and executes licensing structures for the deployment of proprietary assets to government, institutional, and commercial partners at scale.
Manages capital architecture, investment relationships, and the financial instruments through which the organization funds, scales, and protects its long-term agenda.
The Melhem Foundation serves as the philanthropic and impact arm of the Melhem ecosystem. It is focused on expanding access to healthcare, education, and opportunity across underserved regions — particularly in Lebanon, the Middle East, and Africa.
The Foundation's role is not purely charitable. It is strategic — designed to unlock long-term impact, enable access to systems being built across the platform, and support the talent pipelines that the broader organization depends on. By working in parallel with Melhem Scientific and institutional partners, the Foundation ensures that the reach of the platform extends to the communities and populations who need it most, not just those who can pay for it.
Organizes and supports direct medical intervention programs in underserved regions, delivering clinical care and expertise to populations with limited access to formal health systems.
Funds and facilitates educational access for high-potential students across Lebanon, the Middle East, and Africa — building the human capital pipeline aligned with the platform's long-term agenda.
Partners with Melhem Scientific and institutional networks to deliver workforce training, health system development, and institutional strengthening in priority regions.
Melhem Consultancy operates as the advisory and execution interface of the platform. It works with governments, institutions, and healthcare systems to design and implement large-scale initiatives in digital health, artificial intelligence, and infrastructure — including national strategies, hospital optimization, precision health systems, and interoperability frameworks.
Unlike traditional consulting firms, Melhem Consultancy is tightly integrated with Melhem Holdings' proprietary platforms and capabilities. This integration allows it to move beyond strategy into real execution, deployment, and long-term partnership — delivering not recommendations, but outcomes. It is the bridge between institutional ambition and operational reality.
Designs and implements government-level digital health strategies — from policy architecture to full national rollout — with a mandate for execution, not just advisory.
Deploys AI-driven health systems and precision medicine frameworks for national health authorities, hospital networks, and regional health organizations.
Works directly with hospital leadership and health ministries to redesign clinical workflows, operational infrastructure, and data systems for maximum efficiency and outcomes.
Builds the technical and governance frameworks required for health data interoperability across national and regional systems — enabling connected, intelligent health infrastructure at scale.